Riley Hospital
INDIANAPOLIS -- Involving family members of pediatric cancer and hematology patients in medical rounds benefits both the family and the medical team, according to a new Indiana University School of Medicine study.
INDIANAPOLIS -- New findings related to an uncommon genetic disorder may impact the diagnosis and treatment of inflammatory bowel disease (IBD), the most common chronic gastrointestinal illness in children and teens. Two million Americans have IBD which involves inflammation of the gastrointestinal tract.
INDIANAPOLIS -- A new study by researchers from the Automotive Safety Program at Riley Hospital for Children and Indiana University School of Medicine published online July 13, 2009 in the journal Pediatrics reports that the parents of children with special health care needs are doing a good job with the selection of the appropriate child car seat but still need help in using it correctl
INDIANAPOLIS -- A multi-center clinical trial led by a Riley Hospital for Children endocrinologist has found that inhaled growth hormone (GH) is well tolerated by children with GH deficiency and that this easy-to-use method can, over a one-week period, safely deliver GH to the blood stream.
In 1979 Chancellor's Professor David Pisoni brought the first two postdoctoral researchers to Indiana University Bloomington when he was awarded a five-year training grant by the National Institute of Neurological and Communicative Disorders. Today, the same grant supports six postdoctoral researchers, six doctoral students and six medical students in Bloomington and Indianapolis.
INDIANAPOLIS - New guidelines from the American Academy of Pediatrics should eliminate one of the many stresses of bringing a preterm or low birth weight infant home from the hospital.
Pre-school youngsters with type I diabetes can be treated as successfully with insulin pumps as with daily injections, researchers at the Indiana University School of Medicine report. A clinical trial at the Riley Hospital for Children studied 20 patients 5 years old or younger receiving treatment with continuous insulin infusion by pump and 17 who were receiving injection therapy. Physicians compared control of blood sugar levels, parents' satisfaction and safety in both groups. ''Pump therapy was safe and well tolerated,'' says endocrinologist Linda A. DiMeglio, M.D., who led the study.
